Six-minute stepper test for people with peripheral artery disease
Official title: Examination of the Validity and Reliability of 6-minute Stepper Test in Patients With Peripheral Artery Disease
Run by Gazi University · NCT07169045 · Data updated 2026-11-12
This project will test whether the six-minute stepper test can measure exercise ability in adults with peripheral artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Gazi University Academic / other |
| Locations | 1 site (Ankara, Çankaya) |
| Status | Recruiting |
| Started | September 24, 2025 |
| Main results expected | July 24, 2026 |
| Study ends | July 24, 2026 |
| Registry record updated | February 3, 2026 |
| Trial ID | NCT07169045 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are stable adults (18–80 years) with diagnosed peripheral artery disease (ABI criteria or calcified vessels), weighing ≤110 kg, who can safely perform stepper exercise and who volunteer to participate.
✕Probably not a fit
Patients with recent major cardiac events or surgery, unstable coronary disease, uncontrolled diabetes, pulmonary disease, active infection, prior ischemic amputation, pregnancy/breastfeeding, or those unable to step safely (including weight >110 kg) are unlikely to benefit from this test or be eligible for participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will recruit adults aged 18–80 with diagnosed peripheral artery disease at Gazi University's Cardiopulmonary Rehabilitation Unit. Participants will perform the six-minute stepper test (6MST), likely with repeat testing for reliability, alongside reference measures of exercise capacity and related variables such as muscle oxygenation, balance, intermittent claudication pain, lower extremity strength, and arterial stiffness. The study will compare 6MST results with established measures (such as cardiopulmonary exercise testing or other functional tests) to examine agreement and correlations. Data analysis will focus on validity (how well the 6MST reflects true exercise capacity) and test-retest reliability in this patient group.
Why it matters
Potential benefit: If successful, the 6MST could offer a simple, low-cost way to measure exercise capacity and help guide exercise programs for patients with PAD.
How similar studies have gone: The 6MST has shown validity and reliability in various pulmonary and cardiovascular populations, but its use specifically in PAD patients is largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with peripheral artery disease by the Department of Cardiovascular Surgery, * Ankle-brachial index (ABI) ≤1.40 or exercise ABI ≤0.73 or diagnosed with calcified vascular response, in remission and under follow-up, * Stable, * Ages between 18 and 80, * Patients who volunteer to participate in the study will be included. Exclusion Criteria: * Patients will be excluded if they have: * Previously underwent ischaemic amputation, * Unstable coronary artery disease, * Uncontrolled Diabetes Mellitus, * Pulmonary disease, * Acute infection, * Weight \>110 kg because it is the upper limit of the stepper device, * Contraindications to exercise testing per the American Sports Medicine Association, * Pregnant and breastfeeding women, * Patients with PAD who have undergone major surgery or had a myocardial infarction within the last 3 months.
Where it's running
-
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
Ankara, Çankaya, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Nihan KATAYIFÇI — Gazi University
- Study coordinator: Meral BOŞNAK GÜÇLÜ
- Email: merakbosnak@gazi.edu.tr
- Phone: +90(312)2162647
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Reducing blood clots after leg artery procedures with Factor XI inhibitors in adults with PAD
This trial tests two drugs, REGN7508 and REGN9933, to see if they lower the chance of dangerous blood clots after leg artery restoration procedures in adults with peripheral artery disease.
-
Near-infrared light to map blood flow and muscle oxygen use in peripheral artery disease
This project tries to use near-infrared light to measure blood flow and muscle oxygen use in people with peripheral artery disease and see if those measurements predict who will improve after vascular treatments.
-
Detecting lower‑leg peripheral artery disease using segmental pulse arrival time
This trial will test whether measuring segmental pulse arrival time, and whether warming the skin or elevating the foot, can help detect lower‑leg peripheral artery disease in adults aged 19 and older.
-
Algae supplements for heart risk markers and gut health
This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.
-
Using shockwave balloons to treat severe calcification in leg arteries
This study is testing whether shockwave balloon therapy can help people with peripheral artery disease who have severe calcification in their leg arteries feel better and improve blood flow.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.